Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anil Pareek

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Annals of the Rheumatic Diseases|October 15, 2017
Metabolic and cardiovascular benefits of hydroxychloroquine: exploration in a wider population at high CV riskAnil Pareek, Indranil Purkait, Ravi T Mehta, et al.
Journal of Ethnopharmacology|October 22, 2013
Antioxidant and hepatoprotective activity of Fagonia schweinfurthii (Hadidi) Hadidi extract in carbon tetrachloride induced hepatotoxicity in HepG2 cell line and ratsAnil Pareek, Ashok Godavarthi, Roshan Issarani, et al.
The Journal of the Association of Physicians of India|May 8, 2024
Chlorthalidone vs Hydrochlorothiazide for Hypertension-CV Events: Did the Design Influence the Outcome?Anil Pareek, Franz H Messerli, C Venkata S Ram
The Clinical Journal of Pain|July 20, 2010
Efficacy and safety of etodolac-paracetamol fixed dose combination in patients with knee osteoarthritis flare-up: a randomized, double-blind comparative evaluationAnil Pareek, Nitin Chandurkar, Ratnakar Ambade, et al.
International Journal of Cardiology. Hypertension|January 15, 2021
Interamerican Society of Cardiology (IASC) position statement: Chlorthalidone vs. thiazide-<i>type</i> diureticsAnil Pareek, Franz H Messerli, Gustavo Saravia, et al.
International Journal of Pharmaceutics|May 7, 2025
Advancements in superparamagnetic nanogels: A dual-role platform for diagnosis and targeted drug deliveryAnil Pareek, Sanjesh Kumar, Devesh U Kapoor, et al.
Expert Opinion on Pharmacotherapy|June 12, 2009
A randomized, comparative study evaluating the efficacy and tolerability of losartan-low dose chlorthalidone (6.25 mg) combination with losartan-hydrochlorothiazide (12.5 mg) combination in Indian patients with mild-to-moderate essential hypertensionAnil Pareek, Hathur Basavanagowdappa, Shyamsundar Zawar, et al.
Expert Opinion on Pharmacotherapy|October 22, 2008
Comparative evaluation of efficacy and safety of cefotaxime-sulbactam with amoxicillin-clavulanic acid in children with lower respiratory tract infectionsAnil Pareek, Madhuri Kulkarni, Subhashchandra Daga, et al.
Lancet (London, England)|March 16, 2024
Inflammation, infection, and cardiovascular riskAnil Pareek, Nitin Chandurkar, Kumar Naidu, et al.
Journal of Hypertension|October 7, 2020
2020 International Society of Hypertension Guidelines: preference of calcium channel blocker over thiazide-like diuretics lacks evidenceAnil Pareek, C Venkata S Ram, Shashank Joshi, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Annals of the Rheumatic Diseases|October 15, 2017
Metabolic and cardiovascular benefits of hydroxychloroquine: exploration in a wider population at high CV riskAnil Pareek, Indranil Purkait, Ravi T Mehta, et al.
Journal of Ethnopharmacology|October 22, 2013
Antioxidant and hepatoprotective activity of Fagonia schweinfurthii (Hadidi) Hadidi extract in carbon tetrachloride induced hepatotoxicity in HepG2 cell line and ratsAnil Pareek, Ashok Godavarthi, Roshan Issarani, et al.
The Journal of the Association of Physicians of India|May 8, 2024
Chlorthalidone vs Hydrochlorothiazide for Hypertension-CV Events: Did the Design Influence the Outcome?Anil Pareek, Franz H Messerli, C Venkata S Ram
The Clinical Journal of Pain|July 20, 2010
Efficacy and safety of etodolac-paracetamol fixed dose combination in patients with knee osteoarthritis flare-up: a randomized, double-blind comparative evaluationAnil Pareek, Nitin Chandurkar, Ratnakar Ambade, et al.
International Journal of Cardiology. Hypertension|January 15, 2021
Interamerican Society of Cardiology (IASC) position statement: Chlorthalidone vs. thiazide-<i>type</i> diureticsAnil Pareek, Franz H Messerli, Gustavo Saravia, et al.
International Journal of Pharmaceutics|May 7, 2025
Advancements in superparamagnetic nanogels: A dual-role platform for diagnosis and targeted drug deliveryAnil Pareek, Sanjesh Kumar, Devesh U Kapoor, et al.
Expert Opinion on Pharmacotherapy|June 12, 2009
A randomized, comparative study evaluating the efficacy and tolerability of losartan-low dose chlorthalidone (6.25 mg) combination with losartan-hydrochlorothiazide (12.5 mg) combination in Indian patients with mild-to-moderate essential hypertensionAnil Pareek, Hathur Basavanagowdappa, Shyamsundar Zawar, et al.
Expert Opinion on Pharmacotherapy|October 22, 2008
Comparative evaluation of efficacy and safety of cefotaxime-sulbactam with amoxicillin-clavulanic acid in children with lower respiratory tract infectionsAnil Pareek, Madhuri Kulkarni, Subhashchandra Daga, et al.
Lancet (London, England)|March 16, 2024
Inflammation, infection, and cardiovascular riskAnil Pareek, Nitin Chandurkar, Kumar Naidu, et al.
Journal of Hypertension|October 7, 2020
2020 International Society of Hypertension Guidelines: preference of calcium channel blocker over thiazide-like diuretics lacks evidenceAnil Pareek, C Venkata S Ram, Shashank Joshi, et al.
Pageof 7